Cargando…
Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
Clinical guidelines now recognize the importance of a multifactorial approach to managing cardiovascular (CV) risk. This idea was taken a step further with the concept of the Polypill™. There are, however, considerable patent, pharmacokinetic, pharmacodynamic, registration, and cost implications tha...
Autores principales: | Zamorano, José, Edwards, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234127/ https://www.ncbi.nlm.nih.gov/pubmed/22162939 http://dx.doi.org/10.2147/IBPC.S12215 |
Ejemplares similares
-
Antihypertensive and Antihyperlipidemic Activity of Aqueous Methanolic Extract of Rauwolfia Serpentina in Albino Rats
por: Shah, Syed Muhammad Ali, et al.
Publicado: (2020) -
Synchronized separation of atorvastatin—an antihyperlipidemic drug with antihypertensive, antidiabetic, antithrombotic drugs by RP-LC for determination in combined formulations
por: Talluri, M.V.N. Kumar, et al.
Publicado: (2012) -
Severe adverse cutaneous reactions induced by gefitinib combined with antihypertensive and antihyperlipidemic drugs in lung cancer: a case report
por: Shen, Xiao, et al.
Publicado: (2021) -
Modifiable Factors Associated with Non-adherence to Antihypertensive or Antihyperlipidemic Drugs Are Dissimilar: a Multicenter Study Among Patients with Diabetes in Indonesia
por: Alfian, Sofa D., et al.
Publicado: (2020) -
In vivo Antihypertensive and Antihyperlipidemic Effects of the Crude Extracts and Fractions of Moringa stenopetala (Baker f.) Cufod. Leaves in Rats
por: Geleta, Bekesho, et al.
Publicado: (2016)